EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Clinical characteristics of recurrent chronic rhinosinusitis with nasal polyps in Th2-mediated allergic inflammation: development of approaches for targeted therapy

Rimma M. Pestova, Liliya F. Aznabaeva, Elena E. Savelieva

Cytokines and inflammation · 15.06.2026 · 23 (1) · 34-42

DOI: 10.17816/ci704942 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cytokines and inflammation, online erschienen am 15.06.2026. Verfasst von Rimma M. Pestova und 2 weiteren Autor:innen. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Recurrent chronic rhinosinusitis with nasal polyps (RCRSwNP) is characterized by the formation of inflammatory secretions (mucin) of varying consistency within the paranasal sinuses, which influences disease severity and treatment outcomes. Although the role of the Th2 inflammatory pathway is well established, the specific contribution of IL-4 and IL-13 to the development of distinct mucin phenotypes and treatment resistance remains insufficiently elucidated. AIM: This study aimed to identify the features of Th2 cytokine regulation (IL-4 and IL-13) in patients with RCRSwNP to develop approaches for personalized therapy. METHODS: A prospective single-center study included 113 participants: 83 patients with bilateral RCRSwNP who had undergone preventive anti-inflammatory therapy and 30 healthy controls. Patients were divided into groups based on mucin phenotype: watery mucin and dense mucin. Clinical parameters and paranasal sinus CT findings were assessed. Levels of IL-4 and IL-13 in maxillary sinus lavage fluids were determined using enzyme-linked immunosorbent assay (ELISA). Rhinocytological examination was performed, and results were compared with mycological analysis and measurement of specific IgE and IgG antibodies to Candida and Aspergillus. The efficacy of targeted therapy was evaluated in patients resistant to standard treatment. RESULTS: Two mucin phenotypes were identified: watery mucin (n = 43) and dense mucin (n = 40). Patients with dense mucin demonstrated more extensive polypoid disease on CT (p = 0.000031), a higher prevalence of hyperostosis (p = 0.0132), a higher prevalence of hyperdense sinus opacification (p = 0.0006), more frequent intense intraoperative bleeding (p = 0.0005), and a tendency toward more frequent comorbidity with bronchial asthma (p = 0.0556; χ² = 3.6647). Fungi of the genera Candida and Aspergillus were detected in 74.7% of patients (n = 62), comparable to healthy controls (83.3%, n = 25; p = 0.4781). Candida carriage was associated with the formation of specific IgG and IgE antibodies. Assessment of immune responses in Aspergillus carriers revealed no clinically significant levels of specific IgG or IgE antibodies. IL-4 concentrations were significantly higher in patients with dense mucin (p 0.05). IL-13 levels were significantly elevated in the dense mucin group (p 0.05) and correlated with clinical severity (p 0.05). Targeted therapy with dupilumab demonstrated high efficacy (p = 0.0077). CONCLUSION: Dense mucin in RCRSwNP is associated with elevated IL-4 and IL-13 levels, more severe clinical course, and resistance to standard therapy. IL-13 plays a leading role in the formation of the pathological mucin phenotype and mucosal remodeling. These findings support the rationale for targeted therapy in patients with dense mucin. Further multicenter studies with larger sample sizes are required to validate these results.

Zitieren

APA

Pestova, R. M., Aznabaeva, L. F., & Savelieva, E. E. (2026). Clinical characteristics of recurrent chronic rhinosinusitis with nasal polyps in Th2-mediated allergic inflammation: development of approaches for targeted therapy. Cytokines and inflammation, 23(1), 34-42. https://doi.org/10.17816/ci704942

Vancouver

Pestova RM, Aznabaeva LF, Savelieva EE. Clinical characteristics of recurrent chronic rhinosinusitis with nasal polyps in Th2-mediated allergic inflammation: development of approaches for targeted therapy. Cytokines and inflammation. 2026;23(1):34-42. doi:10.17816/ci704942

BibTeX
@article{Pestova2026,
  author = {Pestova, Rimma M. and Aznabaeva, Liliya F. and Savelieva, Elena E.},
  title = {Clinical characteristics of recurrent chronic rhinosinusitis with nasal polyps in Th2-mediated allergic inflammation: development of approaches for targeted therapy},
  journal = {Cytokines and inflammation},
  year = {2026},
  volume = {23},
  number = {1},
  pages = {34--42},
  doi = {10.17816/ci704942}
}
Kostenlos starten →